NAVBO uses AgendaPop as it's Mobile Event App
You can also call contact AgendaPop at:
or call (703) 793-4955
Features of our app can be reveiwed at: http://www.agendapop.com/features/
Princess U II Imoukhuede, Ph.D., Assistant Professor of Bioengineering at the University of Illinois at Urbana-Champaign, has been awarded a National Science Foundation CAREER award for her proposal, “qBio+cBio=sBio: Identifying the Role of Cross-Family Signaling in Angiogenesis.” Dr. Imoukhuede also received the Rose Award for Teaching ExcellenceExcellence from the University of Illinois College of Engineering.
In October of 2016, Iris Jaffe of Tufts University assumed the role of Executive Director of the Molecular Cardiology Research Institute at Tufts Medical Center. In March of this year, Dr. Jaffe was also appointed as the Eliza Kent Mendelsohn Professor of Molecular CardiologyKent Mendelsohn Professor of Molecular Cardiology. Dr. Jaffe’s research combines her expertise in gene transcription and vascular biology with her interests as a clinical cardiologist to explore the molecular mechanisms that contribute to common cardiovascular diseases.
José López, M.D. Professor of Medicine-Hematology at the University of Washington School of Medicine, has co-edited a book, Platelets in Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics: an Update, published in 2017 by Springer (ISBN 978-3-319-47462-5). This volume reviews current science and applications in fields including thrombosis and hemostasis, signal transduction, and non-thrombotic conditions such as inflammation, allergy and tumor metastasis.
Fortune Magazine has recognized Laura Niklason, M.D., Ph.D., Nicholas M. Greene Professor in Anesthesia and Biomedical Engineering at Yale University and founder of Humacyte, Inc., as a member of Fortune’s List of Leaders Transforming Health and Medicine. Dr. Niklason and her colleagues at Humacyte have developed bioengineered blood vessels currently under investigation as vascular grafts in patients with kidney failure. In addition, Dr. Niklason was inducted into the National Academy of Medicine in October of 2016.
Dr. Bing Zhang has relocated from Boston Children’s Hospital to Shanghai Jiao Tong University as Professor and Principal Investigator in the Shanghai Center for Systems Biomedicine. Dr. Zhang subsequently was recognized through China’s Thousand Talents Plan that seeks to recruit “…strategic scientists or leading talents who can make breakthroughs in key technologies or can enhance China’s high-tech industries and emerging
2017 Candidates include:
Guillermo Garcia-Cardena, Brigham and Women's Hospital
Nathan Lawson, University of Massachusetts
Click on their names to open a pdf that includes a CV and letters of support.
To place your vote, click here.
We're looking ahead to Vascular Biology 2019 (October 27-31 at the Asilomar Conference Grounds in Pacific Grove, CA) and we would like input from the NAVBO membership. Vascular Biology 2019 will consist of the Developmental Vascular Biology and Genetics Workshop and the Vascuar Matrix Biology and Bioengineering Workshop. The NAVBO Council and the meeting organizers, Victoria Bautch (UNC Chapel Hill), Courtney Griffin (OMRF), Kayla Bayless (TAMU), Marelene Rabinovitch (Stanford), Linda Demer (UCLA) and Christopher Breuer (Nationwide Children's Hospital), are seeking proposals from NAVBO members for a session developed by members. This new session may or may not be directly related to the workshop themes. The session will have a two-hour time slot, tentatively scheduled for Tuesday afternoon, October 29.
*Please note: You may also consider submitting a proposal for our Vascular Therapeutics session (presented on Wednesday evening, October 30). This session should be organized by two members – one from academia and one from industry (biotech, pharmaceuticals, etc.); the speakers should also represent both environments equally. We suggest four invited talks. If interested, check the appropriate box on the submission form.
Submissions are due April 2, 2018.
Vote by February 24, 2017
Select one candidate. Click on the name to see a brief bio. Click here to Vote.
It will be necessary for you to log-in in order to cast your vote.
The Organizer of this workshop is Masanori Aikawa, Brigham and Women's Hospital/Harvard Medical School. The chosen candidate will co-organize with Dr. Aikawa in 2018 and will be the Organizer for the 2020 Workshop.
William A. Muller, MD, Ph.D.
Magerstadt Professor of Pathology
Professor of Pathology
Northwestern University Feinberg School of Medicine
Dr. Muller is the Magerstadt Professor of Pathology at Northwestern University Feinberg School of Medicine. He received his MD/PhD from Rockefeller University/Cornell Program, where he gained a strong interest in inflammation and immunology while training with Ralph Steinman and Zanvil Cohn. He did a Residency in Pathology at the Brigham and Women’s Hospital with Ramzi Cotran, including two years of research work with Michael Gimbrone, where he gained a strong interest in vascular biology. His research career has married those two passions, studying the role of the endothelial cell in the transendothelial migration (TEM) of leukocytes. His group identified PECAM-1 and CD99 as important regulators of TEM and have been studying the molecular signaling pathways downstream of these molecules in vitro and in murine models of inflammatory diseases. He has been continuously funded by the NIH since 1990, including a MERIT Award (2005-2015). He was elected an AAAS Fellow (2010) and received the Rous Whipple Award from ASIP (2013).
I have been an active member of NAVBO since its inception, serving as Program Committee Chair (2002-2003), President-Elect (2003-2004), President (2004-2005), Councilor (2009-present), and Secretary-Treasurer (2012-present). I served on the Scientific Advisory Boards of the 15th, 17th, and 19th International Vascular Biology Meetings and on the Program Committee for the latter. I attended the previous Vascular Inflammation Workshop as well as its predecessor at the Signaling Workshop in Hyannis.
My goals for this meeting would be to work closely with Dr. Aikawa as well as the organizers of the concurrent Signaling Workshop to identify areas of mutual interest where joint programming would be synergistic and avoid programming simultaneous sessions on similar topics. The scientific sessions would feature the thought leaders in the field as well as up-and-coming junior investigators. The meeting should be a venue to define the limits of our knowledge and identify important questions for future investigation. I would like to implement Poster Discussion sessions, which we have used quite successfully at other meetings, to make the poster sessions more interactive, efficient, and educational.
Ira Tabas, M.D., Ph.D.
Richard J. Stock Professor
Department of Medicine
Professor of Pathology & Cell Biology (in Physiology and Cellular Biophysics)
Dr. Tabas is the Richard J. Stock Professor of Medicine, Cell Biology, and Physiology at Columbia University Medical Center (CUMC). He received his M.D. and Ph.D. (Biochemistry) degrees from Washington University in St. Louis and completed his Internal Medicine and Endocrinology/ Metabolism training at CUMC, with board certification in both disciplines. His research focuses on cardiometabolic disease, with a long history of work in the area of molecular-cellular mechanisms of advanced atherosclerosis. His research has elucidated roles of macrophage endoplasmic reticulum (ER) stress, apoptosis, defective efferocytosis, and defective inflammation resolution in advanced plaque progression. Over the last ten years, Dr. Tabas' laboratory has expanded its interests into an area that is a major driving force behind atherosclerosis, namely, obesity-associated type 2 diabetes (T2D). In particular, the laboratory has discovered a new calcium-ER stress signaling pathway in hepatocytes that contributes to the metabolic disturbances of obesity and diabetes. In both the atherosclerosis and metabolism areas, there is strong emphasis on therapeutic translation. He has lectured worldwide and published over 200 original research articles and reviews. These papers have been published in Cell, Nature, Science, Nature Cell Biology, Nature Reviews Immunology, Cell Metabolism, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, and other top journals. Dr. Tabas also serves on the Board of Reviewing Editors for the journal Science. He was elected to both the Society for Clinical Investigation and the Association of American Physicians. Dr. Tabas' other honors include the American Heart Association Established Investigator Award, the Columbia University Doctor Harold and Golden Lamport Research Award, the American Heart Association/ATVB Council Special Recognition Award, the 2011 Alumni Achievement Award from Washington University School of Medicine, the 2014 Society of Leukocyte Biology Bonazinga award, which is the society's highest honor for excellence in leukocyte biology research, the 2015 Harrington Discovery Institute Innovator-Scholar Award for his work in diabetes, and the 2016 American Heart Association Russell Ross Lectureship Award in Vascular Biology.
As a member of NAVBO, I truly enjoy attending the meetings and interacting with colleagues and particularly young scientists. I find a wonderful complementarity between the work that we do in atherosclerosis, inflammation, and cardiometabolic disease pathophysiology and some of the more traditional areas of interest of NAVBO in vascular biology.
My goals for the 2018 workshop are to continue the tradition of featuring the best mechanistic-based research in vascular inflammation while also making sure that (a) we include a diverse group of presenters and attendees, including young investigators and a good balance of female and male researchers; (b) have ample time for discussion after each talk and also time for informal discussions in between sessions; (c) encourage presentations on disease relevance and translational research, including areas that might be relevant to genomic and precision medicine.
NAVBO’s intent is to continue spreading vascular biology to more people by offering our summer course at more locations including those outside the United States.
Vasculata is a vascular biology boot camp, 3 to 4 days long that emphasizes the use of local faculty for course instruction. To make this possible, NAVBO places Vasculata in sites with a critical mass of vascular biologists. The idea is to have the attendees interact with your faculty, although external speakers may be used.
The host institution will be required to complete an R13 grant application to NHLBI in order to secure funds for scholarships. Ideally, these scholarships will be used to provide registration and housing fees for students that do not have travel funds within their department. Reaching out to schools with a significant population of under-represented minorities is strongly suggested. Apart from soliciting funding from NHLBI, there is very little, if any, need for corporate fundraising. However, we would not discourage this. Corporations could sponsor workshops, meals or outside speakers (if desired).
NAVBO provides some resources to make all this possible. Over the decade that the course has been offered, we have developed self-teaching materials. The most important materials are two spreadsheets. One of these, called the Vasculata Worksheet, is a set of key references, curated, with keywords added, and tied into the lecture material. The second is comprised of a long list of very challenging questions students can use to challenge their knowledge.
A core curriculum is identified within the Vasculata Worksheet. The meeting program should be built around this curriculum; however, we encourage host institutions to flavor the meeting with its own expertise.
Prior to the course, students should be provided with the list of lectures and a précis for each lecture. The précis explains what the students should know before coming to class and suggests appropriate readings in the Vasculata Worksheet. This allows lectures to build on knowledge that the students should already have. Of course not all students will do the work, however those that do will find that they will benefit more from the course with this preparation.
Another way that we make this a great experience for students is by asking the host institution to offer workshops that involve the attendees with local fellows. Sites may, at their discretion also offer course credit or integrate Vasculata with another course.
Another important detail is that the cost of attending Vasculata should be kept as low as possible. In addition to discouraging the raising of funds for visiting speakers, we hope each site will find inexpensive housing for attendees (typically dormitory housing is available in the summer).
Finally, the host site lectures are webcast to remote sites that use the lectures along with their own local faculty.
If you attended Vascular Biology 2017 - please take this quick survey. Your input is invaluable to us as we plan our future meetings.
We especially want your comments about presentations, the mobile event app, and the value that you found in the meeting. Thank you for your time.
Please go to:
VB 2017 Evaluation Form and log in
or complete the evaluation form anonymously by following this link:
Thank you so much for completing the form!!!
See you next year in Newport, Rhode Island!
If you would like to have your conference listed in our Calendar of Events, please complete the information below and submit.
Please allow two days for your conference to be added.
NAVBO is happy to help you in acquiring a Visa in order to facilitate your attendance at one of our meetings by issuing a letter of invitation, however, the following is required:
Prior to receiving a letter of invitation, each individual requesting an invitation letter must first register and pay for the conference. Conference registration fees are refundable (less the designated processing fee) if the visa application is denied. The refund request must be received in writing.
A letter of invitation is issued solely for the purpose of assisting participants with visa applications. Such a letter does not imply any financial obligation on the part of NAVBO. All expenses incurred in relation to the meeting are the sole responsibility of the attendee(s).
Please note that we cannot guarantee that you will receive a visa. The decision to grant visas is at the sole discretion of the Embassy or Consulate offices. NAVBO will not be able to contact or intervene with Embassy or Consulate offices on your behalf. NAVBO cannot change the decision of the Embassy or Consulate offices should your application be denied.
The following information is required before a letter of invitation can be issued:
Your CV (curriculum vitae or resume)
Name as it appears on your passport
Title/Position (Professor, graduate student, postdoctoral fellow, etc.)
City, Province, Country, Postal Code
Personal Street Address
City, Province, Country, Postal Code
Date of issuance
Date of expiration
Place of issue
Date of Birth
Place of birth
You should also indicate briefly why you want to attend the conference.
All letters of invitation are generic in nature and will be signed and sent in PDF format that can be printed by the requester(s). No mailed (postal) letters of invitation will be sent. Due to the costs involved, we cannot send letters of invitation via express mail services.
It is the traveler's responsibility to check and confirm current visa requirements to enter the United States. To see if you require a visa, please visit https://travel.state.gov/content/travel/en/us-visas/visa-information-resources/wizard.html. NAVBO cannot be held responsible for travelers who do not confirm their visa requirements or who do not obtain the appropriate paperwork for travel to the conference.
Another helpful page is https://www.insuremytrip.com/research/us-travel-visa-information/ - please note we are NOT endorsing the services of Insure My Trip.
This procedure is intended to assist participants who need to obtain a visa to attend the conference and is not an official invitation covering fees and/or any other expenses or financial support for attendance. NAVBO does not assume responsibility for the outcome of your visa application.